|
|
| Balance Sheet |
|
| Syngene International Ltd | | Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln | Chairman : Kiran Mazumdar Shaw | | Home : Indian Private | Book Value: 104.1404189 | | BSE Code : 539268 | Market Cap: 28107.14 | | NSE Code : SYNGENE | P / E : 59.07 | |
| |
|
|
|
| (Rs in Cr.) |
 |
 |
| SOURCES OF FUNDS: | | | Share Capital | 401.40 | 400.80 | 400.00 | 400.00 | 200.00 | | Reserves & Surplus | 3217.50 | 2891.20 | 2418.30 | 1774.10 | 1767.20 | | Total Shareholders Funds | 3618.90 | 3292.00 | 2818.30 | 2174.10 | 1967.20 | | Secured Loans | 575.30 | 531.50 | 512.40 | 376.70 | 606.60 | | Unsecured Loans | 382.90 | 785.70 | 691.70 | 762.90 | 451.50 | | Total Debt | 958.20 | 1317.20 | 1204.10 | 1139.60 | 1058.10 | | Total Liabilities | 4577.10 | 4609.20 | 4022.40 | 3313.70 | 3025.30 | | APPLICATION OF FUNDS: | | Gross Block | 4071.20 | 3943.50 | 3460.00 | 3017.20 | 2171.00 | | Less: Accum. Depreciation | 1811.20 | 1550.70 | 1259.00 | 997.50 | 794.20 | | Net Block | 2260.00 | 2392.80 | 2201.00 | 2019.70 | 1376.80 | | Capital Work in Progress | 126.20 | 346.40 | 237.20 | 234.10 | 273.70 | | Investments | 940.80 | 1034.40 | 702.30 | 776.70 | 716.30 | | Inventories | 332.80 | 179.40 | 59.60 | 25.20 | 43.40 | | Sundry Debtors | 484.40 | 508.20 | 474.40 | 398.20 | 338.70 | | Cash and Bank Balance | 509.30 | 515.10 | 638.20 | 280.30 | 435.40 | | Loans and Advances | 1316.60 | 709.70 | 664.60 | 513.40 | 551.10 | | Current Liabilities | 1332.20 | 994.60 | 895.10 | 880.70 | 673.30 | | Provisions | 60.80 | 82.20 | 59.80 | 53.20 | 36.80 | | Net Current Assets | 1250.10 | 835.60 | 881.90 | 283.20 | 658.50 | | Miscellaneous Expenses not w/o | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | | Total Assets | 4577.10 | 4609.20 | 4022.40 | 3313.70 | 3025.30 | | Contingent Liabilities | 621.90 | 547.80 | 859.60 | 849.20 | 671.60 |
|
|
|
|
|